ARYX
Price:
$0.0005
Market Cap:
$237.58K
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. The company uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of original drugs. Its products in clinical development portfolio include Tecarfarin (ATI-5923), an oral anticoagulant, which is in Phase III clinical development for the treatment of patients who are at risk for the formation of dangerous blood clots; and Budiodarone (ATI-2042), an oral antiarrhythmic agent that is in Phase IIb clinical development for the treatment of atrial fibrillation, a form of irregular heartbeat. The company's other clinical development products ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-11-07
Stock Exchange
PNK
Ticker
ARYX
According to ARYx Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.01. This represents a change of 42.59% compared to the average of 0.71 of the last 4 quarters.
The mean historical Current Ratio of ARYx Therapeutics, Inc. over the last ten years is 2.58. The current 1.01 Current Ratio has changed 3.84% with respect to the historical average. Over the past ten years (40 quarters), ARYX's Current Ratio was at its highest in in the December 2007 quarter at 4.82. The Current Ratio was at its lowest in in the March 2005 quarter at 0.
Average
2.58
Median
3.58
Minimum
0
Maximum
4.82
Discovering the peaks and valleys of ARYx Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Current Ratio = 4.82
Minimum Annual Increase = 0%
Minimum Annual Current Ratio = 0
Year | Current Ratio | Change |
---|---|---|
2009 | 1.01 | -75.62% |
2008 | 4.16 | -13.72% |
2007 | 4.82 | 8.13% |
2006 | 4.46 | 24.65% |
2005 | 3.58 | Infinity% |
2004 | 0 | 0% |
The current Current Ratio of ARYx Therapeutics, Inc. (ARYX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.33
5-year avg
3.61
10-year avg
2.58
ARYx Therapeutics, Inc.’s Current Ratio is less than Medicure Inc. (0), less than Mountain High Acquisitions Corp. (1.87), greater than Creative Edge Nutrition, Inc. (0.31), greater than OWC Pharmaceutical Research Corp. (0.34), greater than Ascend Wellness Holdings, Inc. (0), less than Incannex Healthcare Limited (2.29), less than Silver Spike Investment Corp. (2.88), less than Phibro Animal Health Corporation (6.09), less than Supernus Pharmaceuticals, Inc. (2.94), less than null (1.91),
Company | Current Ratio | Market cap |
---|---|---|
0 | $6.57M | |
1.87 | $220.00 | |
0.31 | $46.30K | |
0.34 | $49.75K | |
0 | $179.98M | |
2.29 | $44.81M | |
2.88 | $66.72M | |
6.09 | $919.03M | |
2.94 | $1.91B | |
1.91 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ARYx Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ARYx Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ARYx Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for ARYx Therapeutics, Inc. (ARYX)?
What is the highest Current Ratio for ARYx Therapeutics, Inc. (ARYX)?
What is the 3-year average Current Ratio for ARYx Therapeutics, Inc. (ARYX)?
What is the 5-year average Current Ratio for ARYx Therapeutics, Inc. (ARYX)?
How does the current Current Ratio for ARYx Therapeutics, Inc. (ARYX) compare to its historical average?